Insulet Corporation

NasdaqGS PODD

Insulet Corporation Market Capitalization on January 27, 2025: USD 19.35 B

Insulet Corporation Market Capitalization is USD 19.35 B on January 27, 2025, a 38.91% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Insulet Corporation 52-week high Market Capitalization is USD 19.66 B on January 24, 2025, which is 1.61% above the current Market Capitalization.
Insulet Corporation 52-week low Market Capitalization is USD 11.27 B on May 13, 2024, which is -41.77% below the current Market Capitalization.
Insulet Corporation average Market Capitalization for the last 52 weeks is USD 14.76 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGS: PODD

Insulet Corporation

CEO	Dr. James R. Hollingshead Ph.D.
IPO Date	May 15, 2007
Location	United States
Headquarters	100 Nagog Park
Employees	3,000
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Key trends

Past 5 years